![CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-00007-0/MediaObjects/41598_2021_7_Fig1_HTML.png)
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports
Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
![B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-020-00092-2/MediaObjects/41573_2020_92_Fig1_HTML.png)
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery
![Anti-CD20 therapy and B cells in autoimmunity. Autoreactive B cells... | Download Scientific Diagram Anti-CD20 therapy and B cells in autoimmunity. Autoreactive B cells... | Download Scientific Diagram](https://www.researchgate.net/publication/5788240/figure/fig1/AS:264519654047747@1440077808928/Anti-CD20-therapy-and-B-cells-in-autoimmunity-Autoreactive-B-cells-play-a-role-in.png)
Anti-CD20 therapy and B cells in autoimmunity. Autoreactive B cells... | Download Scientific Diagram
![B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-022-00619-z/MediaObjects/41571_2022_619_Fig1_HTML.png)
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology
![Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations](https://www.frontiersin.org/files/Articles/484200/fimmu-10-02458-HTML/image_m/fimmu-10-02458-g001.jpg)